Cambrex Corporation Company Information

Profile

Company Overview – CBM (NYSE) Public Traded Company Cambrex Corporation, founded in 1981, operates as an innovative global life sciences company that provides products and services for the development and commercialization of new and generic therapeutics worldwide. Its products consist of active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. The company primarily supplies its products and services to innovator and generic pharmaceutical companies. The company sells its products directly, as well as through independent agents to pharmaceutical and generic drug companies, as well as to companies that discover and commercialize new small molecule human therapeutics using organic chemistry. The company exports various products globally, principally Western Europe and Asia. Cambrex is a strong global organization headquartered in East Rutherford, New Jersey with approximately 900 employees in the United States, Europe and India. It has six operating and manufacturing facilities in the US (Iowa), Europe (Germany, Sweden, Italy, Estonia) and India that produce generic and branded active pharmaceutical ingredients (APIs), advanced intermediates, drug delivery products, and provides custom development and manufacturing services.